Biondvax Pharm (BVAXF) 0.2000 $BVAXF
BiondVax to Initiate the Process for Trading the Company's Shares in the US through ADR
PR Newswire - Wed Apr 02, 7:46AM CDT
BiondVax Pharmaceuticals Ltd (TASE: BNDX), developer of a universal flu vaccine, announced today that its Board of Directors has approved initiation of the process for listing the Company's shares for trading in the US through American Depository Receipt (ADR).
2013 Report on the International Vaccine Market - Global Forecasts To 2022
M2 - Fri Jan 03, 8:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/3gg35h/vaccine_market_by) has announced the addition of the "2013 Report on the International Vaccine Market - Global Forecasts To 2022" report to their offering. In general, the vaccine technology market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies. This report analyzes the vaccine technology market both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available products. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate. The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided. An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed. As well as technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Technology Snapshot (Page No. - 31) 4 Vaccine Research Portfolio 5 Value Chain Analysis 6 Market Landscape 7 Technology Adoption 8 Investment Analysis 9 Competitive Landscape 10 Regulatory Landscape 11 Patent Analysis 12 Analyst Recommendations 13 Company Profiles Companies Mentioned: - Aduro Biotech - Alphavax - Antigen Express, INC - Bavarian Nordic - Biondvax Pharmaceuticals LTD - Genticel - Glaxo Smithkline PLC - Immune Targeting Systems (ITS) - Immunobiology LTD - Liquidia Technologies - Merck & CO, INC - Novartis AG - Pfizer, INC - Prokarium - Sanofi For more information visit http://www.researchandmarkets.com/research/3g..._market_by
Vaccine Market by Technology & Types, Various Classes & Indications - Global Forecasts To 2022
M2 - Wed Aug 14, 5:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zhq7rz/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology & Types, Various Classes & Indications - Global Forecasts To 2022" report to their offering. The vaccine technology market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following issues: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Technology Snapshot 4 Vaccine Research Portfolio 4.1 Global Research Portfolio - Research And Development Network 4.2 Emerging Approaches To Vaccine Developments 4.3 Key Research Centres 5 Value Chain Analysis 5.1 Overview 5.2 Cold Chain Management 5.3 Key Stakeholders 5.4 Gap Analysis 5.5 Porters Five Force Analysis 6 Market Landscape 7 Technology Adoption 7.1 Factors That Drive Adoption Of Vaccine Technologies 7.2 U.S. & Canada 7.3 U.K, Germany, France, Italy 7.4 China, India 7.5 Australia & Africa 8 Investment Analysis 8.1 Investor Network 8.2 Investment Funding Analysis 8.3 Top Funding Organizations 9 Competitive Landscape 9.1 Competitive Landscape Analysis - Overview 9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2012 - 2013) 9.3 Vaccine Candidates In Pipeline - Allergy 9.4 Vaccine Candidates In Pipeline - Cancer 9.5 Vaccine Candidates In Pipeline - Infectious Diseases 9.6 Vaccine Candidates In Pipeline - Others 10 Regulatory Landscape 10.1 Regulatory Landscape - Overview 10.2 Regulations - Geographic 11 Patent Analysis 11.1 Patent Analysis - Overview 11.2 Patent Analysis By Company 12 Analyst Recommendations 12.1 Introduction 12.2 Technology Management Strategies 13 Company Profiles 14 Appendix Companies Mentioned - Aduro Biotech - Alphavax - Antigen Express, INC - Bavarian Nordic - Biondvax Pharmaceuticals LTD - Genticel - Glaxo Smithkline PLC - Immune Targeting Systems (ITS) - Immunobiology LTD - Liquidia Technologies - Merck & CO, INC - Novartis AG - Pfizer, INC - Prokarium - Sanofi For more information visit http://www.researchandmarkets.com/research/zh..._market_by
BiondVax to Initiate the Process for Trading the Company's Shares in the US through ADR
PR Newswire - Wed Apr 02, 7:46AM CDT
BiondVax Pharmaceuticals Ltd (TASE: BNDX), developer of a universal flu vaccine, announced today that its Board of Directors has approved initiation of the process for listing the Company's shares for trading in the US through American Depository Receipt (ADR).
2013 Report on the International Vaccine Market - Global Forecasts To 2022
M2 - Fri Jan 03, 8:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/3gg35h/vaccine_market_by) has announced the addition of the "2013 Report on the International Vaccine Market - Global Forecasts To 2022" report to their offering. In general, the vaccine technology market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies. This report analyzes the vaccine technology market both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available products. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate. The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided. An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed. As well as technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Technology Snapshot (Page No. - 31) 4 Vaccine Research Portfolio 5 Value Chain Analysis 6 Market Landscape 7 Technology Adoption 8 Investment Analysis 9 Competitive Landscape 10 Regulatory Landscape 11 Patent Analysis 12 Analyst Recommendations 13 Company Profiles Companies Mentioned: - Aduro Biotech - Alphavax - Antigen Express, INC - Bavarian Nordic - Biondvax Pharmaceuticals LTD - Genticel - Glaxo Smithkline PLC - Immune Targeting Systems (ITS) - Immunobiology LTD - Liquidia Technologies - Merck & CO, INC - Novartis AG - Pfizer, INC - Prokarium - Sanofi For more information visit http://www.researchandmarkets.com/research/3g..._market_by
Vaccine Market by Technology & Types, Various Classes & Indications - Global Forecasts To 2022
M2 - Wed Aug 14, 5:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zhq7rz/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology & Types, Various Classes & Indications - Global Forecasts To 2022" report to their offering. The vaccine technology market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following issues: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Technology Snapshot 4 Vaccine Research Portfolio 4.1 Global Research Portfolio - Research And Development Network 4.2 Emerging Approaches To Vaccine Developments 4.3 Key Research Centres 5 Value Chain Analysis 5.1 Overview 5.2 Cold Chain Management 5.3 Key Stakeholders 5.4 Gap Analysis 5.5 Porters Five Force Analysis 6 Market Landscape 7 Technology Adoption 7.1 Factors That Drive Adoption Of Vaccine Technologies 7.2 U.S. & Canada 7.3 U.K, Germany, France, Italy 7.4 China, India 7.5 Australia & Africa 8 Investment Analysis 8.1 Investor Network 8.2 Investment Funding Analysis 8.3 Top Funding Organizations 9 Competitive Landscape 9.1 Competitive Landscape Analysis - Overview 9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2012 - 2013) 9.3 Vaccine Candidates In Pipeline - Allergy 9.4 Vaccine Candidates In Pipeline - Cancer 9.5 Vaccine Candidates In Pipeline - Infectious Diseases 9.6 Vaccine Candidates In Pipeline - Others 10 Regulatory Landscape 10.1 Regulatory Landscape - Overview 10.2 Regulations - Geographic 11 Patent Analysis 11.1 Patent Analysis - Overview 11.2 Patent Analysis By Company 12 Analyst Recommendations 12.1 Introduction 12.2 Technology Management Strategies 13 Company Profiles 14 Appendix Companies Mentioned - Aduro Biotech - Alphavax - Antigen Express, INC - Bavarian Nordic - Biondvax Pharmaceuticals LTD - Genticel - Glaxo Smithkline PLC - Immune Targeting Systems (ITS) - Immunobiology LTD - Liquidia Technologies - Merck & CO, INC - Novartis AG - Pfizer, INC - Prokarium - Sanofi For more information visit http://www.researchandmarkets.com/research/zh..._market_by
